<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04829370</url>
  </required_header>
  <id_info>
    <org_study_id>20170903R</org_study_id>
    <nct_id>NCT04829370</nct_id>
  </id_info>
  <brief_title>Clinical Application of Patented Lyophilized PLT in Acne Scar Repairment.</brief_title>
  <official_title>Clinical Application of Patented Lyophilized PLT in Acne Scar Repairment.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shin Kong Wu Ho-Su Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Spirit Scientific</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shin Kong Wu Ho-Su Memorial Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      All kinds of skin problems will cause a person's life caused by varying degrees of trouble,&#xD;
      especially issues at face. No matter diseases or aging would cause mental pressure and the&#xD;
      inconvenience in different ages.&#xD;
&#xD;
      Scar caused by acne is the most common skin issue amount young people. While acne recovering,&#xD;
      due to the destruction of collagen forming fibrous tissue, and scars be left. Clinical&#xD;
      treatments are facial laser, argon laser and carbon dioxide laser. With the combination of&#xD;
      rejuvenation to accelerate growth of collagen when needed. According to journal articles,&#xD;
      facial laser combined with Platelet-rich plasma is more curative than facial laser treatment&#xD;
      alone and can significantly reduce side effects (Dermatol Surg. 2014 Feb;40(2):152-61).&#xD;
&#xD;
      Platelet has been valued in regeneration medicine due to its various growth factors with&#xD;
      repairment, induction and promotion functions. Moreover, low risk of allergy for it is an&#xD;
      autologous material. Platelet had been officially applied in orthopedics and more clinical&#xD;
      studies in many other fields. Nowadays, preparation of PRP is by single-use centrifuge tube,&#xD;
      patients have to go through blood collection process every time before therapy due to short&#xD;
      shelf life of PRP. Meanwhile, amount of platelet in PRP would be different due to difference&#xD;
      of individual, health condition and separation methods. Thus, leaving unknown of active&#xD;
      principle and uncertainty of treatments.&#xD;
&#xD;
      In this trial, a patented technique of lyophilized PLT preparation method is applied, collect&#xD;
      250 c.c. of blood specimen by using blood bag, separate platelet in germ-free clean room,&#xD;
      then lyophilize platelet to extend shelf life to at least three years after quantifying&#xD;
      platelet amount. Therefore, treatment could be done after simple dissolution process of PLT&#xD;
      leads to the convenience of multiple therapy lessons.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 20, 2020</start_date>
  <completion_date type="Actual">October 30, 2020</completion_date>
  <primary_completion_date type="Actual">September 28, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>A prospective, single-blind, parallel study at a single health care center.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>adverse effect assessment</measure>
    <time_frame>20 weeks</time_frame>
    <description>adverse effect assessment, Safety</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Global assessment of acne scar</measure>
    <time_frame>20 weeks</time_frame>
    <description>5-point grading of acne scar</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>wound healing rate</measure>
    <time_frame>20 weeks</time_frame>
    <description>7-days grading of wound healing</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Atrophic Acne Scar</condition>
  <arm_group>
    <arm_group_label>PLT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>All subjects are treated with fractional carbon dioxide laser, then applied 2 mL PLT solution (dissolved in normal saline) on the right face.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>All subjects are treated with fractional carbon dioxide laser, the left face (control group) be applied 2 mL normal saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PLT</intervention_name>
    <description>The study will be conducted by using a fractional carbon dioxide laser for acne scar treatment. After the treatment, each patient enrolled will be applied 2 mL PLT solution on the right face. Treatment mentioned above will be repeated every 3 to 4 weeks, overall 4 times treatment and one month follow up after fourth treatment. Every record will be documented in questionnaires by the principal investigator and the patient itself. Moreover, VISIA is applied for objective observation, such as spots, wrinkles, texture, pores, UV spots, brown spots, red area, and porphyrins could be objectively analyzed.</description>
    <arm_group_label>PLT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>The study will be conducted by using a fractional carbon dioxide laser for acne scar treatment. After the treatment, each patient enrolled left face be applied 2 mL normal saline.&#xD;
Treatment mentioned above will be repeated every 3 to 4 weeks, overall 4 times treatment and one month follow up after fourth treatment. Every record will be documented in questionnaires by the principal investigator and the patient itself. Moreover, VISIA is applied for objective observation, such as spots, wrinkles, texture, pores, UV spots, brown spots, red area, and porphyrins could be objectively analyzed.</description>
    <arm_group_label>Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - all subjects of acne scars are defined of grades 1, 2, and 3 [Goodman and Baron Grading&#xD;
        scale] were enrolled in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Exclusion criteria included treatment with any laser device treatment to the face&#xD;
             within 1 month, use of systemic retinoids within 3 months, pregnancy or lactation, a&#xD;
             history of hypertrophic scarring or keloids, cancer therapies, uncontrolled diabetes,&#xD;
             chronic liver or kidney disease, cardiovascular disease or hematologic disorders.&#xD;
             Subjects were requested to avoid using any topical products containing alpha-hydroxy&#xD;
             acids and salicylic acid on the face during the study period.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chieh-Chen Huang, Shin Kong Wu Ho Su Memorial, M</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Dermatology, Shin Kong Wu Ho Su Memorial Hospital,</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shin Kong Wu Ho-Su Memorial Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. J Invest Dermatol. 2009 Sep;129(9):2136-41. doi: 10.1038/jid.2009.47. Epub 2009 Mar 12.</citation>
    <PMID>19282841</PMID>
  </reference>
  <reference>
    <citation>Collier CN, Harper JC, Cafardi JA, Cantrell WC, Wang W, Foster KW, Elewski BE. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol. 2008 Jan;58(1):56-9. Epub 2007 Oct 22. Erratum in: J Am Acad Dermatol. 2008 May;58(5):874. Cafardi, Jennifer A [added].</citation>
    <PMID>17945383</PMID>
  </reference>
  <reference>
    <citation>Layton AM. Optimal management of acne to prevent scarring and psychological sequelae. Am J Clin Dermatol. 2001;2(3):135-41. Review.</citation>
    <PMID>11705090</PMID>
  </reference>
  <reference>
    <citation>Moradi Tuchayi S, Makrantonaki E, Ganceviciene R, Dessinioti C, Feldman SR, Zouboulis CC. Acne vulgaris. Nat Rev Dis Primers. 2015 Sep 17;1:15029. doi: 10.1038/nrdp.2015.29. Review.</citation>
    <PMID>27189872</PMID>
  </reference>
  <reference>
    <citation>Connolly D, Vu HL, Mariwalla K, Saedi N. Acne Scarring-Pathogenesis, Evaluation, and Treatment Options. J Clin Aesthet Dermatol. 2017 Sep;10(9):12-23. Epub 2017 Sep 1. Review.</citation>
    <PMID>29344322</PMID>
  </reference>
  <reference>
    <citation>Fabbrocini G, Annunziata MC, D'Arco V, De Vita V, Lodi G, Mauriello MC, Pastore F, Monfrecola G. Acne scars: pathogenesis, classification and treatment. Dermatol Res Pract. 2010;2010:893080. doi: 10.1155/2010/893080. Epub 2010 Oct 14.</citation>
    <PMID>20981308</PMID>
  </reference>
  <reference>
    <citation>Dunn LK, O'Neill JL, Feldman SR. Acne in adolescents: quality of life, self-esteem, mood, and psychological disorders. Dermatol Online J. 2011 Jan 15;17(1):1. Review.</citation>
    <PMID>21272492</PMID>
  </reference>
  <reference>
    <citation>Sánchez Viera M. Management of acne scars: fulfilling our duty of care for patients. Br J Dermatol. 2015 Jul;172 Suppl 1:47-51. doi: 10.1111/bjd.13650. Review.</citation>
    <PMID>25597636</PMID>
  </reference>
  <reference>
    <citation>Ong MW, Bashir SJ. Fractional laser resurfacing for acne scars: a review. Br J Dermatol. 2012 Jun;166(6):1160-9. doi: 10.1111/j.1365-2133.2012.10870.x. Epub 2012 May 8. Review.</citation>
    <PMID>22296284</PMID>
  </reference>
  <reference>
    <citation>Manuskiatti W, Triwongwaranat D, Varothai S, Eimpunth S, Wanitphakdeedecha R. Efficacy and safety of a carbon-dioxide ablative fractional resurfacing device for treatment of atrophic acne scars in Asians. J Am Acad Dermatol. 2010 Aug;63(2):274-83. doi: 10.1016/j.jaad.2009.08.051.</citation>
    <PMID>20633798</PMID>
  </reference>
  <reference>
    <citation>Sclafani AP, Romo T 3rd, Ukrainsky G, McCormick SA, Litner J, Kevy SV, Jacobson MS. Modulation of wound response and soft tissue ingrowth in synthetic and allogeneic implants with platelet concentrate. Arch Facial Plast Surg. 2005 May-Jun;7(3):163-9.</citation>
    <PMID>15897404</PMID>
  </reference>
  <reference>
    <citation>Hom DB, Linzie BM, Huang TC. The healing effects of autologous platelet gel on acute human skin wounds. Arch Facial Plast Surg. 2007 May-Jun;9(3):174-83.</citation>
    <PMID>17519207</PMID>
  </reference>
  <reference>
    <citation>Dougherty EJ. An evidence-based model comparing the cost-effectiveness of platelet-rich plasma gel to alternative therapies for patients with nonhealing diabetic foot ulcers. Adv Skin Wound Care. 2008 Dec;21(12):568-75. doi: 10.1097/01.ASW.0000323589.27605.71.</citation>
    <PMID>19065083</PMID>
  </reference>
  <reference>
    <citation>Jee CH, Eom NY, Jang HM, Jung HW, Choi ES, Won JH, Hong IH, Kang BT, Jeong DW, Jung DI. Effect of autologous platelet-rich plasma application on cutaneous wound healing in dogs. J Vet Sci. 2016 Mar;17(1):79-87. doi: 10.4142/jvs.2016.17.1.79. Epub 2016 Mar 22.</citation>
    <PMID>27051343</PMID>
  </reference>
  <reference>
    <citation>Tambella AM, Attili AR, Dupré G, Cantalamessa A, Martin S, Cuteri V, Marcazzan S, Del Fabbro M. Platelet-rich plasma to treat experimentally-induced skin wounds in animals: A systematic review and meta-analysis. PLoS One. 2018 Jan 11;13(1):e0191093. doi: 10.1371/journal.pone.0191093. eCollection 2018. Review.</citation>
    <PMID>29324848</PMID>
  </reference>
  <reference>
    <citation>Leo MS, Kumar AS, Kirit R, Konathan R, Sivamani RK. Systematic review of the use of platelet-rich plasma in aesthetic dermatology. J Cosmet Dermatol. 2015 Dec;14(4):315-23. doi: 10.1111/jocd.12167. Epub 2015 Jul 23. Review.</citation>
    <PMID>26205133</PMID>
  </reference>
  <reference>
    <citation>Shin MK, Lee JH, Lee SJ, Kim NI. Platelet-rich plasma combined with fractional laser therapy for skin rejuvenation. Dermatol Surg. 2012 Apr;38(4):623-30. doi: 10.1111/j.1524-4725.2011.02280.x. Epub 2012 Jan 30.</citation>
    <PMID>22288389</PMID>
  </reference>
  <reference>
    <citation>Zhu JT, Xuan M, Zhang YN, Liu HW, Cai JH, Wu YH, Xiang XF, Shan GQ, Cheng B. The efficacy of autologous platelet-rich plasma combined with erbium fractional laser therapy for facial acne scars or acne. Mol Med Rep. 2013 Jul;8(1):233-7. doi: 10.3892/mmr.2013.1455. Epub 2013 May 2.</citation>
    <PMID>23653117</PMID>
  </reference>
  <reference>
    <citation>Gawdat HI, Hegazy RA, Fawzy MM, Fathy M. Autologous platelet rich plasma: topical versus intradermal after fractional ablative carbon dioxide laser treatment of atrophic acne scars. Dermatol Surg. 2014 Feb;40(2):152-61. doi: 10.1111/dsu.12392. Epub 2013 Dec 19. Erratum in: Dermatol Surg. 2014 May;40(5):601.</citation>
    <PMID>24354616</PMID>
  </reference>
  <reference>
    <citation>Na JI, Choi JW, Choi HR, Jeong JB, Park KC, Youn SW, Huh CH. Rapid healing and reduced erythema after ablative fractional carbon dioxide laser resurfacing combined with the application of autologous platelet-rich plasma. Dermatol Surg. 2011 Apr;37(4):463-8. doi: 10.1111/j.1524-4725.2011.01916.x.</citation>
    <PMID>21481064</PMID>
  </reference>
  <reference>
    <citation>Hui Q, Chang P, Guo B, Zhang Y, Tao K. The Clinical Efficacy of Autologous Platelet-Rich Plasma Combined with Ultra-Pulsed Fractional CO(2) Laser Therapy for Facial Rejuvenation. Rejuvenation Res. 2017 Feb;20(1):25-31. doi: 10.1089/rej.2016.1823. Epub 2016 Jun 23.</citation>
    <PMID>27222038</PMID>
  </reference>
  <reference>
    <citation>Kieb M, Sander F, Prinz C, Adam S, Mau-Möller A, Bader R, Peters K, Tischer T. Platelet-Rich Plasma Powder: A New Preparation Method for the Standardization of Growth Factor Concentrations. Am J Sports Med. 2017 Mar;45(4):954-960. doi: 10.1177/0363546516674475. Epub 2016 Dec 13.</citation>
    <PMID>27903591</PMID>
  </reference>
  <reference>
    <citation>Goodman GJ, Baron JA. Postacne scarring--a quantitative global scarring grading system. J Cosmet Dermatol. 2006 Mar;5(1):48-52.</citation>
    <PMID>17173571</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>April 1, 2021</study_first_submitted>
  <study_first_submitted_qc>April 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2021</study_first_posted>
  <last_update_submitted>April 1, 2021</last_update_submitted>
  <last_update_submitted_qc>April 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Platelet</keyword>
  <keyword>PLT</keyword>
  <keyword>Growth factor</keyword>
  <keyword>Acne scar repairment</keyword>
  <keyword>Laser</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acne Vulgaris</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

